Alamar Biosciences Quarterly Balance Sheet
NASDAQ: ALMRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alamar Biosciences financial position
As of Jun 30, 2026, Alamar Biosciences reported total assets of $391.0 million against total liabilities of $78.1 million. Shareholders' equity stood at $312.9 million, or 80.0% of assets. The company held $133.0 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 11.85, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Alamar Biosciences balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Cash & Equivalents | 132.97M | 64.59M | — | — |
| Short-Term Investments | 117.08M | 0 | — | — |
| Receivables | 20.34M | 19.52M | — | — |
| Inventory | 45.41M | 39.93M | — | — |
| Total Current Assets | 331.38M | 141.47M | — | — |
| Property, Plant & Equipment | 13.36M | 10.47M | — | — |
| Long-Term Investments | — | 0 | — | — |
| Total Assets | 390.98M | 186.45M | — | — |
| Accounts Payable | 13.79M | 5.63M | — | — |
| Total Current Liabilities | 27.96M | 24.05M | — | — |
| Total Liabilities | 78.12M | 129.53M | — | — |
| Shareholders' Equity | 312.86M | -178.07M | -146.61M | -140.29M |
| Retained Earnings | -203.30M | -190.10M | — | — |
| Net Cash (Debt) | 250.05M | 64.59M | — | — |
This table shows 4 quarterly periods of Alamar Biosciences's balance sheet, from Q2 2026 back to Q? 2025, across 14 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ALMR's reporting calendar. What is a balance sheet?